Page contents Full notification Final report General information GMO characterization European Commission administrative Information Return to search

Full notification Final report - General information Notification Number B/NL/23/005 Member State to which the notification was sent Netherlands Date of acknowledgement from the Member State Competent Authority 01/06/2023 Title of the Project Vaccination of chickens , under field conditions, with two recombinant herpesvirus of turkey to monitor the immunological responses in time. One herpesvirus with an insection of HA H5 gen of a LPAI virus (Vectormune HVT-AIV) and one existing recombinant herpesvirus of turkey, with a VP2 gene of infectious bursal disease, with a HA H5 gene construct (Vaxxitek HVT-IBD-H5). Proposed period of release: 01/06/2023 to 30/01/2030 Name of the Institute(s) or Company(ies) Gezondheidsdienst voor Dieren B.V. (Royal GD), postbus 9, Deventer, Netherlands
Is the same GMO been notified elsewhere by the same notifier? No Has the same GMO been notified elsewhere by the same notifier? No GMO characterization GMO is a: DNA Virus Identity of the GMO: Two different vaccines are applied: Both vaccines contain a live cell-associated Herpesvirus of turkey (HVT) based on the HVT FC-126 strain. HVT or Meleagrid herpes virus 1 (MeHV-1) belongs to the family of the Herpesviridae, subfamily Alphaherpesvirinae, genus Mardivirus One vaccine contains the HVT FC126 strain an insertions of the HA H5 gene of Influenza virus. One vaccine contains the HVT FC126 strain with an insection of the VP2 gene of infectious bursal disease, in which an insertion of HA H5 construct is added. Information relating to the recipient or parental organisms from which the GMO is derived Common Name: Genus: Mardivirus Species: Meleagrid herpesvirus 1 Subspecies: Strain: FC 126 Pathovar: European Commission administrative Information Consent given by the Member State Competent Authority: Yes
08/18/2023